from Reuters: Health News https://ift.tt/3aHO3st
via IFTTT
Monday, January 27, 2020
UK healthcare cost agency rejects J&J's nasal spray for depression
Britain's healthcare cost agency on Tuesday recommended against including Johnson & Johnson's nasal spray for depression, Spravato, in the country's healthcare network, citing uncertainties over its clinical and cost effectiveness.
from Reuters: Health News https://ift.tt/3aHO3st
via IFTTT
from Reuters: Health News https://ift.tt/3aHO3st
via IFTTT
0 comments:
Post a Comment